Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 94 P67 | DOI: 10.1530/endoabs.94.P67

SFEBES2023 Poster Presentations Metabolism, Obesity and Diabetes (70 abstracts)

The effect of snack foods containing rare sugars on glycaemic response, gut hormones and satiety in healthy UK adults

Alison Smith 1 , Amanda Avery 2 , Rebecca Ford 2 , Aurelie Goux 3 , Neil Mukherjee 4 , Qian Yang 2 & Preeti Jethwa 2


1Univesity of Nottingham, Nottingham, United Kingdom. 2University of Nottingham, Nottingham, United Kingdom. 3Mondelez International, Saclay, France. 4Mondelez International, East Hanover, USA


Dietary guidelines in the UK and worldwide recommend reducing the quantity of free sugars in the diet. The consumption of foods high in free sugars can lead to postprandial hyperglycaemia and hyperinsulinemia, which have been implicated in the development of metabolic diseases including type 2 diabetes and obesity. Rare sugars (naturally occurring monosaccharides which hardly exist in nature) have been found to suppress the postprandial elevation in blood glucose and improve glycaemic control when consumed alongside a carbohydrate load. However, the effect of rare sugars when consumed as part of a confectionery product has not been widely studied. Additionally, there is limited research on the effects of rare sugar consumption on appetite. Here we conducted a double-blind, randomised controlled study to investigate the effects of replacing sucrose with the rare sugars tagatose or arabinose in sweet snacks. We measured liking of the snacks and postprandial blood glucose, insulin and gut hormones alongside effects on appetite and satiety. We observed that there was no difference in liking of the products as indicated by a 9-point hedonic scale, while results to date indicate significant differences in peak glucose concentration between samples, and differences in satiety after consumption of samples. Our results will demonstrate whether the replacement of sucrose with tagatose or arabinose can reduce the elevation in blood glucose after eating a sweet snack, and whether satiety or food intake are affected. We anticipate this will aid in the development of reduced- sugar confectionary which could be beneficial for those at risk of or living with metabolic disease.

Volume 94

Society for Endocrinology BES 2023

Glasgow, UK
13 Nov 2023 - 15 Nov 2023

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.